NCT05408689

Effects of Transcutaneous Electrical Nerve Stimulation (TENS) to Improve the Cognitive Functions in Older Adults

Completed NA Last updated 22 September 2023

What this trial tests

NA trial testing T1 TENS in Mild Cognitive Impairment in 90 participants. Completed in 23 March 2023.

Timeline

23 May 2022

Primary endpoint
23 March 2023

23 March 2023

Quick facts

Lead sponsor	The Hong Kong Polytechnic University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	90
Start date	23 May 2022
Primary completion	23 March 2023
Estimated completion	23 March 2023
Sites	1 location across Hong Kong

Drugs / interventions tested

• T1 TENS
• Concha TENS
• Control

Conditions studied

• Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →

Sponsor

The Hong Kong Polytechnic University

Who can join

Adults 55 to 85, any sex, with Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recent evidence has shown that transcutaneous electrical nerve stimulation (TENS) was effective in improving the cognitive function in healthy adult and people with dementia. However, lacking of evidence investigated the effect of TENS in improving the cognitive function and reversing the occurrence of dementia during the period of mild cognitive impairment (MCI), which is the crucial period to prevent the significant loss of cognition function. Therefore, the main objective of this study is to investigate the optimal TENS treatment protocol in improving the cognitive function in older adults with MCI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.